Suppr超能文献

无创体内冠状动脉血栓成像。

Noninvasive In Vivo Coronary Artery Thrombus Imaging.

机构信息

BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

出版信息

JACC Cardiovasc Imaging. 2023 Jun;16(6):820-832. doi: 10.1016/j.jcmg.2022.10.002. Epub 2022 Dec 14.

Abstract

BACKGROUND

The diagnosis and management of myocardial infarction are increasingly complex, and establishing the presence of intracoronary thrombosis has major implications for both the classification and treatment of myocardial infarction.

OBJECTIVES

The aim of this study was to investigate whether positron emission tomographic (PET) and computed tomographic (CT) imaging could noninvasively detect in vivo thrombus formation in human coronary arteries using a novel glycoprotein IIb/IIIa receptor antagonist-based radiotracer, F-GP1.

METHODS

In a single-center observational case-control study, patients with or without acute myocardial infarction underwent coronary F-GP1 PET/CT angiography. Coronary artery F-GP1 uptake was assessed visually and quantified using maximum target-to-background ratios.

RESULTS

F-GP1 PET/CT angiography was performed in 49 patients with and 50 patients without acute myocardial infarction (mean age: 61 ± 9 years, 75% men). Coronary F-GP1 uptake was apparent in 39 of the 49 culprit lesions (80%) in patients with acute myocardial infarction. False negative results appeared to relate to time delays to scan performance and low thrombus burden in small-caliber distal arteries. On multivariable regression analysis, culprit vessel status was the only independent variable associated with higher F-GP1 uptake. Extracoronary cardiac F-GP1 findings included a high frequency of infarct-related intramyocardial uptake (35%) as well as left ventricular (8%) or left atrial (2%) thrombus.

CONCLUSIONS

Coronary F-GP1 PET/CT angiography is the first noninvasive selective technique to identify in vivo coronary thrombosis in patients with acute myocardial infarction. This novel approach can further define the role and location of thrombosis within the heart and has the potential to inform the diagnosis, management, and treatment of patients with acute myocardial infarction. (In-Vivo Thrombus Imaging With F-GP1, a Novel Platelet PET Radiotracer [iThrombus]; NCT03943966).

摘要

背景

心肌梗死的诊断和治疗变得越来越复杂,确定冠状动脉内血栓的存在对心肌梗死的分类和治疗都有重大影响。

目的

本研究旨在探讨一种新型糖蛋白 IIb/IIIa 受体拮抗剂放射性示踪剂 F-GP1 是否可以通过正电子发射断层扫描(PET)和计算机断层扫描(CT)成像非侵入性地检测人类冠状动脉内的血栓形成。

方法

在一项单中心观察性病例对照研究中,急性心肌梗死患者或无急性心肌梗死患者接受了冠状动脉 F-GP1 PET/CT 血管造影。通过视觉评估和最大靶背比来定量评估冠状动脉 F-GP1 摄取。

结果

F-GP1 PET/CT 血管造影在 49 例急性心肌梗死患者和 50 例无急性心肌梗死患者中进行(平均年龄:61±9 岁,75%为男性)。在 49 例急性心肌梗死患者中,39 例(80%)罪犯病变中可见冠状动脉 F-GP1 摄取。假阴性结果似乎与扫描执行时间延迟和小口径远端动脉中低血栓负荷有关。多变量回归分析显示,罪犯血管状态是唯一与 F-GP1 摄取更高相关的独立变量。心脏外的 F-GP1 发现包括与梗死相关的心肌内摄取的高频率(35%)以及左心室(8%)或左心房(2%)血栓。

结论

冠状动脉 F-GP1 PET/CT 血管造影是首例非侵入性选择性技术,可在急性心肌梗死患者中识别体内冠状动脉血栓。这种新方法可以进一步确定血栓在心脏内的作用和位置,并有可能为急性心肌梗死患者的诊断、管理和治疗提供信息。(新型血小板 PET 放射性示踪剂 F-GP1 用于体内血栓成像[Ithrombus];NCT03943966)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验